๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Calcitriol for bone loss in patients with primary biliary cirrhosis

โœ Scribed by Susumu Shiomi; Kyoko Masaki; Daiki Habu; Tadashi Takeda; Shuhei Nishiguchi; Tetsuo Kuroki; Hironobu Ochi


Publisher
Springer Japan
Year
1999
Tongue
English
Weight
81 KB
Volume
34
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Impaired sulfoxidation in patients with
โœ Bruce F. Scharschmidt; John R. Lake ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 263 KB ๐Ÿ‘ 1 views

An impaired sulfoxidation pathway has been implicated in the pathogenesis of chlorpromazineinduced hepatotoxicity. Since some patients with chronic chlorpromazine-induced cholestasis may have features of primary biliary cirrhosis, we studied the ability to sulfoxidate the amino acid analogue 5'-carb

Sjรถgren's syndrome in patients with prim
โœ Epaminondas V. Tsianos; Jay H. Hoofnagle; Philip C. Fox; Margaret Alspaugh; E. A ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 509 KB

Symptomatology and objective findings of Sjogren's syndrome were evaluated in 38 consecutive patients with primary biliary cirrhosis. Symptoms of Sjogren's syndrome were present in 18 (47.4%) patients, but were severe enough to warrant therapy in only four (10.6%). Nineteen patients consented to eva

Quality of life in patients with primary
โœ Renรฉe Eugรฉnie Poupon; Yves Chrรฉtien; Olivier Chazouillรจres; Raoul Poupon; Judith ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views

The impact of primary biliary cirrhosis (PBC) on health-related quality of life (HRQOL) is poorly documented. We assessed quality of life in a group of 276 unselected patients with PBC using the Nottingham Health Profile (NHP). This is a generic scale that assesses six major areas commonly associate

Parenteral calcitonin for metabolic bone
โœ Andrea Crosignani; Pier Maria Battezzati; Walter Albisetti; Giuseppe Grandinetti ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 543 KB

No satisfactory treatment is available for metabolic bone disease associated with primary biliary cirrhosis. On the basis of the similarities to postmenopausal osteoporosis, the rationale exists for calcitonin to be tested in clinical studies in patients with primary biliary cirrhosis-associated ost